These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 13034159)
21. Advances in the treatment of cardiovascular disease. Lawrie TD Practitioner; 1969 Oct; 203(216):460-7. PubMed ID: 4901132 [No Abstract] [Full Text] [Related]
22. [The use of cardiac glycosides in therapeutic practice (a review of the literature)]. Neporadnyĭ MD; Denysiuk VH; Mazepa MA; Vatseba NS Lik Sprava; 1994; (9-12):19-22. PubMed ID: 7604573 [No Abstract] [Full Text] [Related]
23. [Disputable problems concerning the use of certain methods of treatment of cardiovascular diseases]. Chazov EI Ter Arkh; 1975; 47(5):33-44. PubMed ID: 240212 [No Abstract] [Full Text] [Related]
29. [Studies on the efficacy of cardiac glycosides in patients of a large old age home]. Iven A Med Monatsschr; 1966 Dec; 20(12):567-9. PubMed ID: 5980275 [No Abstract] [Full Text] [Related]
30. Nuclear medical investigations on the effect of Miroton on end-diastolic volume and left ventricular ejection fraction. Koppenhagen K; Raab E; Grasmugg B Methods Find Exp Clin Pharmacol; 1986 Oct; 8(10):643-5. PubMed ID: 3784704 [No Abstract] [Full Text] [Related]
31. On the treatment of acute cerebral and cardiac blood circulation disorders. MULLER R; SCHILD W Munch Med Wochenschr; 1955 Aug; 97(33):1060-1. PubMed ID: 13265675 [No Abstract] [Full Text] [Related]
32. [Cumulative effects of lanata glycosides]. Feldenkirchen A Med Welt; 1966 Sep; (36):1906-9. PubMed ID: 5922122 [No Abstract] [Full Text] [Related]
33. [Strophantin and other digitalis derivatives in therapy of cardiac diseases]. PESEC A Prakt Arzt; 1951 Oct; 5(53):1320-3. PubMed ID: 14883082 [No Abstract] [Full Text] [Related]
34. [Experiences with oleander glycosides]. PISCHEL W Medizinische; 1955 Sep; (39):1387-8. PubMed ID: 13272556 [No Abstract] [Full Text] [Related]
35. [Some pathogenetic characteristics of the development of circulatory insufficiency in the aged and the principles of treating it with cardiac glycosides]. Morozov KA; Slupskiĭ NN; Goriainova AN; Koriakin NN Ter Arkh; 1974; 46(12):25-33. PubMed ID: 4454017 [No Abstract] [Full Text] [Related]
36. [Effect of convalloside on cardiovascular insufficiency]. SHARLAI RI; SEMENKO IF Ter Arkh; 1955; 27(4):51-5. PubMed ID: 13256408 [No Abstract] [Full Text] [Related]
37. [Treatment of cardiac insufficiency with large doses of digitalin]. MAVRODINOV N Cas Lek Cesk; 1951 Oct; 90(41):1197-9. PubMed ID: 14879424 [No Abstract] [Full Text] [Related]
38. [Effect of cardiac glycosides and ATP on the indices of myocardial bioelectrical activity and contractile function in cardiovascular insufficiency]. Kovshar' FV; Kit SM; Arzhanykh NG; Babenko NA; Boĭchuk RV Farm Zh; 1975; (5):55-7. PubMed ID: 773674 [No Abstract] [Full Text] [Related]
39. The value of drugs in heart disease. WHIMSTER WS Med Press; 1951 Dec; 226(23):558-61. PubMed ID: 14890275 [No Abstract] [Full Text] [Related]
40. [On the combined use of adonis vernalis with cardiac glycosides and strophanthin derivatives in treating patients with circulatory insufficiency]. Gubergrits AIa; Leshchinskiĭ LA Sov Med; 1968 Jan; 31(1):23-7. PubMed ID: 5691025 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]